These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2669920)

  • 1. Treatment decisions in advanced ovarian cancer.
    Cody MM; Slevin ML
    Br J Cancer; 1989 Aug; 60(2):155-6. PubMed ID: 2669920
    [No Abstract]   [Full Text] [Related]  

  • 2. An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.
    Br J Cancer; 1990 Apr; 61(4):495-6. PubMed ID: 2184877
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversy in treatment of advanced ovarian cancer.
    Scambia G; Salutari V; Amadio G
    Lancet Oncol; 2013 Sep; 14(10):920-1. PubMed ID: 23993374
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer?
    Gurbuz A; Karateke A; Kabaca C; Kir G; Cetingoz E
    Int J Gynecol Cancer; 2006; 16 Suppl 1():307-12. PubMed ID: 16515610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living Through Ovarian Cancer Treatment: Acute and Long-Term Toxicities of Chemotherapy for Advanced-Stage Disease.
    Gockley A; Wright A
    Hematol Oncol Clin North Am; 2018 Dec; 32(6):1073-1085. PubMed ID: 30390761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced ovarian cancer.
    Kennedy BJ
    Minn Med; 1979 Jul; 62(7):525. PubMed ID: 492101
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of advanced ovarian cancer.
    Casey MJ
    Conn Med; 1974 Jan; 38(1):1-3. PubMed ID: 4813666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of neoadjuvant chemotherapy in the advanced ovarian cancer].
    Mataga V; Matković V
    Lijec Vjesn; 2013; 135(1-2):21-6. PubMed ID: 23607173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of carboplatin in treating patients with advanced ovarian cancer].
    Pawlicki M; Koralewski P
    Ginekol Pol; 1992 Aug; 63(8):416-9. PubMed ID: 1304531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance chemotherapy in advanced ovarian cancer.
    Piver MS; Muggia FM; Brady MF; Alvarez R
    J Clin Oncol; 2000 Apr; 18(8):1803-5. PubMed ID: 10764445
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
    Vergote I; du Bois A; Amant F; Heitz F; Leunen K; Harter P
    Gynecol Oncol; 2013 Jan; 128(1):6-11. PubMed ID: 23006973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment outcomes for advanced ovarian cancers with peritoneal dissemination].
    Oe S; Hasegawa K; Ichikawa R; Torii Y; Kato R; Komiyama S; Udagawa Y
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):591-7. PubMed ID: 21498987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Eisenkop SM; Spirtos NM; Friedman RL
    Gynecol Oncol; 1999 Aug; 74(2):311-2. PubMed ID: 10419754
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy in advanced ovarian cancer.
    Izard M
    BMJ; 1992 Jan; 304(6819):119. PubMed ID: 1531310
    [No Abstract]   [Full Text] [Related]  

  • 15. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neoadjuvant chemotherapy on primary treatment interval in patients with advanced ovarian cancer.
    Gasparri ML; Perniola G; Di Donato V
    Int J Gynecol Cancer; 2011 Dec; 21(9):1517. PubMed ID: 22123709
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy in advanced ovarian cancer.
    Stewart LA; Guthrie D; Parmar MK; Williams CJ
    BMJ; 1992 Jan; 304(6819):119. PubMed ID: 1531311
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.
    Baratti D; Kusamura S; Deraco M
    Lancet Oncol; 2014 Jun; 15(7):e249. PubMed ID: 24872106
    [No Abstract]   [Full Text] [Related]  

  • 19. Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.
    Shimokata T; Ando Y
    Lancet Oncol; 2014 Jun; 15(7):e249-50. PubMed ID: 24872105
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy in advanced ovarian cancer.
    Cruickshank DJ
    BMJ; 1991 Nov; 303(6812):1269. PubMed ID: 1747658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.